226 related articles for article (PubMed ID: 35345077)
1. Clinical features & treatment of early-stage gastric mucosa-associated lymphoid tissue lymphoma.
Yang H; Jielili A; Cao Z; Yuan T
Indian J Med Res; 2021 Mar; 154(3):504-508. PubMed ID: 35345077
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Efficacy of Radiotherapy in
Park BS; Lee SH
Korean J Gastroenterol; 2019 Jan; 73(1):19-25. PubMed ID: 30690954
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
5. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
[TBL] [Abstract][Full Text] [Related]
6. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
Montalban C; Santon A; Boixeda D; Bellas C
Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658
[TBL] [Abstract][Full Text] [Related]
7. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
Al-Taie O; Al-Taie E; Fischbach W
Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: a single-center experience.
Ryu KD; Kim GH; Park SO; Lee KJ; Moon JY; Jeon HK; Baek DH; Lee BE; Song GA
Gut Liver; 2014 Jul; 8(4):408-14. PubMed ID: 25071906
[TBL] [Abstract][Full Text] [Related]
10. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
Ferreri AJ; Govi S; Ponzoni M
Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
12. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A
Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Abe S; Oda I; Inaba K; Suzuki H; Yoshinaga S; Nonaka S; Morota M; Murakami N; Itami J; Kobayashi Y; Maeshima AM; Saito Y
Jpn J Clin Oncol; 2013 Sep; 43(9):917-22. PubMed ID: 23878345
[TBL] [Abstract][Full Text] [Related]
14. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
15. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
[TBL] [Abstract][Full Text] [Related]
16. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
[TBL] [Abstract][Full Text] [Related]
17. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication.
El-Zahabi LM; Jamali FR; El-Hajj II; Naja M; Salem Z; Shamseddine A; El-Saghir NS; Zaatari G; Geara F; Soweid AM
Gastrointest Endosc; 2007 Jan; 65(1):89-96. PubMed ID: 17185085
[TBL] [Abstract][Full Text] [Related]
18. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
20. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
